Navigation Links
NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa
Date:9/22/2010

y markets with strong economic growth and increased demand for improved health care and more effective products. We strongly believe that Abstral™ has a great potential in the territory and will contribute significantly to physicians' abilities to treat patients experiencing breakthrough cancer pain, hence improving quality of life for these patients."

Torbjorn Bjerke President and CEO of Orexo

"This agreement with NewBridge will enable sales of Abstral™ in additional geographic territories and is another step in developing Abstral™ into a global brand. Our partnership with NewBridge will allow Abstral™ to be available for thousand of doctors to help them manage patients suffering breakthrough cancer pain."

About Abstral™

Abstral™ is a fast-dissolving tablet for sub-lingual administration of fentanyl, intended for the management of breakthrough cancer pain in patients who are already receiving opioid analgesics. It is based on Orexo's unique and patented sublingual tablet technology in which a rapidly dissolving tablet is placed under the tongue and the active substance is absorbed by the mucous membrane. Currently Abstral™ is sold in fourteen countries in Europe, and reached sales of 7.4 M pounds in the first half of 2010.

About Breakthrough Cancer Pain

Breakthrough pain ("BTP") is an acute and often severe flare of pain experienced by patients suffering from cancer that occurs even though a person may be taking opioid pain relief medicine regularly for their persistent pain. It is known as breakthrough pain because it is pain that "breaks through" a regular pain medicine schedule. It may be caused by the cancer itself or it may be related to cancer treatment. For some people, breakthrough pain occurs during certain everyday activities, such as walking or dressing. For others, it occurs unexpectedly without any apparent cause.

Between 64% and 89% o
'/>"/>

SOURCE NewBridge Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 Reportlinker.com announces ... in its catalogue: Portugal Pharmaceuticals ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes ... View: Faster-than-expected economic growth last quarter has led ... slightly upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... , July 28, 2014  Serco Inc., ... announced the Company has been awarded a re-compete ... Command (NEMSCOM) and its Deployable Medical Systems.  Serco ... medical personnel to provide world-class healthcare to meet ... environment across the globe. The five year contract ...
(Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, in ... of LEGENDplex™ Data Analysis Software, an OEM software ... cytometers.  BioLegend develops and offers varieties of bead-based ... With the support of VigeneTech,s data analysis software, ... analyzed and easily reported LEGENDplex™ ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
(Date:7/28/2014)... (PRWEB) July 28, 2014 Camp ... a new camp property in Cornville, AZ. The ... ill children with the opportunity to attend medically ... and families. The organization offers a variety of ... with chronic and life threatening illnesses including: Illness ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... just milliseconds to look at someone,s face and judge them ... that certain facial features seem to trigger specific first impressions ... of the mouth, for example, appear directly linked to whether ... The study findings suggest that first impressions are ...
(Date:7/28/2014)... TX (PRWEB) July 28, 2014 Ticket ... vs. AS Roma tickets in Dallas, TX at the ... July 24th in the USA and it is an eight ... from around the world including teams from La Liga, Serie ... teams that will battle it out on the pitch include: ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3
... Jolt of java better than a nap to prevent mistakes, ... news for javaholics: A new review suggests that caffeine consumption ... 15 percent of workers in industrialized countries are thought to ... can disrupt their body clocks. Some suffer from shift-work disorder, ...
... trouble, experts say , WEDNESDAY, May 12 (HealthDay News) -- ... maintain could make life better for people who rely on ... defibrillator delivers an electric shock to restart a heart that ... Americans each year. Current models require careful surgery to run ...
... a significant predictor of responses to vaccines, according to ... Health. They examined published data from numerous adult and ... fundamental, but often overlooked predictor of vaccine response that ... The review is featured in the May 2010 issue ...
... Medical Researchers at the University of Alberta reported today evidence ... as potential therapy for perhaps the deadliest of all human ... is published at the journal Science Translational Medicine , ... Science; it appears today at the journal,s web site ...
... Researchers at Queen,s University have developed a new ... the way doctors manage prostate cancer treatment. It will ... a gene called PTEN that is associated with an ... In-Situ Hybridization (FISH) platform uses DNA probes to analyze ...
... ... Expansion of Their Candy Store, bwcliffordcandy.com with New Products, Industry Related News and Educational ... , ... 2010 -- BW Clifford proudly announces the expansion of their candy store , ...
Cached Medicine News:Health News:New Implanted Defibrillator May Be Simpler, Safer 2Health News:New Implanted Defibrillator May Be Simpler, Safer 3Health News:Response to vaccines could depend on your sex 2Health News:DCA research on brain cancer 2Health News:DCA research on brain cancer 3Health News:Online Candy Store BW Clifford Launches New Candy Lines and Industry News Resources 2
Inquire...
... a powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up to two ... instruments including vacuum ovens, concentrators, gel dryers, and ... PEEK head resistant to chemicals and heat load ...
... pumps deliver critical performance for all vacuum ... optimizes pump performance to suit all applications. ... convenient checking of proper oil levels at ... is designed to work with all Thermo ...
... two-stage, oil-sealed, rotary vane vacuum pumps specifically ... pump comes complete with a GBORK (Gas ... Mist Filter (EMF-10). The GBORK allows the ... keep the oil clean without losing oil. ...
Medicine Products: